Skip to main content
Coromandel International Limited logo

Coromandel International Limited — Investor Relations & Filings

Ticker · COROMANDEL ISIN · INE169A01031 LEI · 335800U73K3HJSQKT249 BSE.NS Manufacturing
Open in API
Filings indexed 1,915 across all filing types
Latest filing 2025-12-04 Regulatory Filings
Country IN India
Listing BSE.NS COROMANDEL

About Coromandel International Limited

https://www.coromandel.biz/

Coromandel International Limited is a provider of comprehensive agri-solutions, operating across the agricultural value chain. The company specializes in the manufacturing and marketing of phosphatic fertilizers, specialty nutrients, and organic fertilizers. Its crop protection segment offers a broad range of insecticides, fungicides, and herbicides designed to enhance crop yields and quality. Additionally, the company provides farm mechanization services and operates a large network of retail centers that offer agricultural inputs, technical advice, and soil testing services to the farming community. Through its integrated business model, the company focuses on delivering innovative products and sustainable farming practices to improve agricultural productivity. Its operations are supported by advanced research and development facilities and an extensive distribution infrastructure.

Recent filings

Filing Released Lang Actions
Disclosure under Regulation 30 of SEBI LODR Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a formal disclosure submitted under Regulation 30 of the SEBI Listing Regulations, which pertains to continuous disclosure obligations for listed companies in India. It details a demand order from a tax authority regarding alleged excess input tax credit claims, including amounts of tax, interest, and penalty. The document is a regulatory announcement about a legal/tax matter affecting the company, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but is a compliance disclosure about a regulatory/legal issue. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-12-04 English
Change in Management
Regulatory Filings
2025-12-01 English
Please refer attachment
Regulatory Filings Classification · 75% confidence The document is an official stock exchange filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying the outcome of a Board Meeting. It covers multiple board decisions—investment approval, establishment of a subsidiary, and changes in senior management personnel—without providing substantive financial statements or the full board materials. This is a general regulatory announcement (a “Regulatory Filing”) rather than a specific financial report, management discussion, or standalone capital-raising or share issuance document. Therefore, it best fits the Regulatory Filings category.
2025-12-01 English
Outcome of Board Meeting
Regulatory Filings Classification · 82% confidence The document is an SEBI Listing Regulation 30 disclosure notifying stock exchanges of the outcome of a Board Meeting, covering multiple topics (approval of investments/capital raise, setting up a subsidiary, and senior management changes). It is a general regulatory announcement rather than a standalone financial report or specific form. Therefore, it falls under the general Regulatory Filings category (RNS) as a composite regulatory announcement.
2025-12-01 English
Please refer attachment
Regulatory Filings Classification · 85% confidence The document is a stock‐exchange filing under SEBI (Listing Obligations) Regulation 30 reporting the outcome of a Board meeting (investment approvals, subsidiary formation, senior management changes). It is not an annual or interim financial report, earnings release, M&A proxy, or dividend notice. Rather, it is a miscellaneous regulatory disclosure required by the stock exchange, so it best fits the “Regulatory Filings” category (RNS).
2025-12-01 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the uploading of an Investor Presentation for an upcoming Investor & Analyst Meet. It references the presentation being available on the company's website and is dated November 30, 2025. The document does not contain any financial data or detailed report content itself, but rather announces the availability of the presentation. Given the short length (1224 characters) and the nature of the content, this fits the category of an Investor Presentation (IP) announcement. It is not a full report or financial statement, nor is it a regulatory filing or certification. Therefore, the correct classification is Investor Presentation (IP).
2025-11-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.